EISSN 2148-5607

TJG IS INDEXED IN SCI-EXPANDED AND PUBMED IMPACT FACTOR: 1.4

Turkish Journal of Gastroenterology

35 414 2024

Submission to First Decision = 31 Days

HIGHLY CITED ARTICLES

HBV and HCV are the risk factors in CCA

Tan et al.

Serum resolvin levels in irritable bowel syndrome

Karatay and Gül Utku

Microbial improvement after intervention

Qian et al.

18F-FDGPET/CT in gallbladder carcinoma

Arslan et al.

Bezoar in endoscopy

Gökbulut et al.

Effect of vitamin D on CD40L gene expression in UC

Sharifi et al.

ERCP for acute cholangitis

Khamaysi and Taha

Inborn metabolic causes of fatty liver disease

Yıldız and Sivri

Gastric and small intestinal TSA

Kiremitci et al.

COVID-19 in Hepatology and Liver transplantation

Kabaçam et al.

Editorial

A retrospective trial comparing 5-ASA plus ciprofloxacin and metronidazole with 5-ASA and corticosteroids in the treatment of active Crohn's disease

Erkan PARLAK ¹ , Aysel ÜLKER ² , Ülkü DAĞLI ³ , Canan ALKIM ⁴

Author Affiliation(s)

1.

Department of Gastroenterology, Türkiye Yüksek İhtisas Hospital, Ankara

2.

Departments of Gastroenterology and Hematology, Türkiye Yüksek İhtisas Hospital, Ankara

3.

Türkiye yüksek İhtisas Hastanesi Gastroenteroloji Kliniği, Ankara

4.

T.Y.İ.H. Gastroenteroloji Kliniği İ.B.H. Ünitesi, Ankara

Turk J Gastroenterol 2000; 11: 227-230

Keywords : Crohn hastalığı, metronidazol, siprofloksasin 5-ASA, kortikosteroid.

Read: 1329 Published: 25 July 2019

Volume 11, Issue 3, September 2000

Previous Article